This was in agreement with previous findings illustrating that IM-induced long-term KIT inhibition causes a feedback activation of FGFR-mediated signaling in GIST, thereby suggesting that FGFR inhibition may improve the long-term efficacy of IM in GIST patients [17]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.